Home
About
Product
magNews
Career
Contact Us
中文
English
Medical Updates
Corporate
Industry
Technology
Medical Updates
Medical Updates
Bedside Echo-Guided Implantation of MoyoAssist® as a Bridge to Heart Transplantation
2025-08-20
Medical Updates
MoyoAssist® Facilitates Safe and Complete CHIP-PCI in Patient with Heart and Renal Failure
2025-07-30
Medical Updates
MoyoAssist® Bridges a patient with advanced acute heart failure to Successful Transplantation
2025-04-16
Medical Updates
Successful Application of MoyoAssist® in Bridging to Long-Term LVAD
2025-04-09
Medical Updates
Bedside Echo-Guided Implantation of MoyoAssist® as a Bridge to Heart Transplantation
2025-08-20
Medical Updates
MoyoAssist® Facilitates Safe and Complete CHIP-PCI in Patient with Heart and Renal Failure
2025-07-30
Medical Updates
Zhujiang Hospital Transitions from ECMO + IABP to MoyoAssist® in the Management of Cardiogenic Shock
2025-04-30
Medical Updates
MoyoAssist® Bridges a patient with advanced acute heart failure to Successful Transplantation
2025-04-16
Medical Updates
Rapid Postoperative Recovery Achieved with MoyoAssist® in High-Risk Cardiac Surgery
2025-04-12
Medical Updates
Successful Application of MoyoAssist® in Bridging to Long-Term LVAD
2025-04-09
Medical Updates
High-Risk Coronary Revascularization Supported by MoyoAssist® Magnetic Levitation
2025-04-02
Medical Updates
MoyoAssist® Supports Single-Session TAVR-PCI in a High-Risk Elderly Patient
2024-12-16
Medical Updates
MoyoAssist® Extra-VAD Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China
2024-06-28
Medical Updates
First Patient with NyokAssist™ Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventi
2023-08-23
1
2
1/2
》
Tags:
Procedure,
Cardiovascular disease,
Nanjing First Hospital,
Renal Failure,
heart failure.heart transplant,
Zhujiang Hospital,
Southern Medical University,
LVAD,
heart transplantation,
Extra-Ventricular Assist Device,
TOP